These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18160213)

  • 1. Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line.
    Persson F; Olofsson A; Sjögren H; Chebbo N; Nilsson B; Stenman G; Aman P
    Cancer Lett; 2008 Feb; 260(1-2):37-47. PubMed ID: 18160213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of well-differentiated/de-differentiated liposarcomas by high-resolution oligonucleotide array-based comparative genomic hybridization.
    Tap WD; Eilber FC; Ginther C; Dry SM; Reese N; Barzan-Smith K; Chen HW; Wu H; Eilber FR; Slamon DJ; Anderson L
    Genes Chromosomes Cancer; 2011 Feb; 50(2):95-112. PubMed ID: 21117066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
    Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
    Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of amplified and highly expressed genes in amplicons of the T-cell line huT78 detected by cDNA microarray CGH.
    Meléndez B; Martínez-Delgado B; Cuadros M; Fernández V; Díaz-Uriarte R; Benítez J
    Mol Cancer; 2005 Jan; 4(1):5. PubMed ID: 15656903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
    Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
    Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
    Creytens D; Van Gorp J; Speel EJ; Ferdinande L
    Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays.
    Heidenblad M; Hallor KH; Staaf J; Jönsson G; Borg A; Höglund M; Mertens F; Mandahl N
    Oncogene; 2006 Nov; 25(53):7106-16. PubMed ID: 16732325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH.
    Weng WH; Wejde J; Ahlén J; Pang ST; Lui WO; Larsson C
    Cancer Genet Cytogenet; 2004 Apr; 150(1):27-32. PubMed ID: 15041220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
    Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
    Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14-q15 and 6q23 amplifications.
    Chibon F; Mariani O; Derré J; Mairal A; Coindre JM; Guillou L; Sastre X; Pédeutour F; Aurias A
    Genes Chromosomes Cancer; 2004 May; 40(1):32-7. PubMed ID: 15034865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
    Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
    Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization.
    Rücker FG; Bullinger L; Schwaenen C; Lipka DB; Wessendorf S; Fröhling S; Bentz M; Miller S; Scholl C; Schlenk RF; Radlwimmer B; Kestler HA; Pollack JR; Lichter P; Döhner K; Döhner H
    J Clin Oncol; 2006 Aug; 24(24):3887-94. PubMed ID: 16864856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
    Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
    Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions.
    Pedeutour F; Maire G; Pierron A; Thomas DM; Garsed DW; Bianchini L; Duranton-Tanneur V; Cortes-Maurel A; Italiano A; Squire JA; Coindre JM
    Virchows Arch; 2012 Jul; 461(1):67-78. PubMed ID: 22678079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct MDM2 and P14ARF expression and centrosome amplification in well-differentiated liposarcomas.
    Perucca-Lostanlen D; Rostagno P; Grosgeorge J; Marcié S; Gaudray P; Turc-Carel C
    Genes Chromosomes Cancer; 2004 Feb; 39(2):99-109. PubMed ID: 14695989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A different view on DNA amplifications indicates frequent, highly complex, and stable amplicons on 12q13-21 in glioma.
    Fischer U; Keller A; Leidinger P; Deutscher S; Heisel S; Urbschat S; Lenhof HP; Meese E
    Mol Cancer Res; 2008 Apr; 6(4):576-84. PubMed ID: 18403636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
    Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
    Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pairwise comparison of genomic imbalances between primary and recurrent well differentiated liposarcomas.
    Micci F; Bjerkehagen B; Heim S
    Cancer Genet Cytogenet; 2007 Oct; 178(2):163-7. PubMed ID: 17954275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas.
    Pérot G; Derré J; Coindre JM; Tirode F; Lucchesi C; Mariani O; Gibault L; Guillou L; Terrier P; Aurias A
    Cancer Res; 2009 Mar; 69(6):2269-78. PubMed ID: 19276386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monosomy 7 and absence of 12q amplification in two cases of spindle cell liposarcomas.
    Italiano A; Chambonniere ML; Attias R; Chibon F; Coindre JM; Pedeutour F
    Cancer Genet Cytogenet; 2008 Jul; 184(2):99-104. PubMed ID: 18617058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.